ArticleGynecologic oncology reports2024

Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma with

Jenny L Soiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.